Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

Associations of type 2 diabetes and diabetes treatment with breast cancer risk and mortality: a population-based cohort study among British women.

Redaniel MT, Jeffreys M, May MT, Ben-Shlomo Y, Martin RM.

Cancer Causes Control. 2012 Nov;23(11):1785-95. doi: 10.1007/s10552-012-0057-0. Epub 2012 Sep 13.

PMID:
22971998
2.

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes.

Currie CJ, Poole CD, Gale EA.

Diabetologia. 2009 Sep;52(9):1766-77. doi: 10.1007/s00125-009-1440-6. Epub 2009 Jul 2.

PMID:
19572116
3.

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.

Bowker SL, Majumdar SR, Veugelers P, Johnson JA.

Diabetes Care. 2006 Feb;29(2):254-8.

PMID:
16443869
4.

Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study.

Azoulay L, Schneider-Lindner V, Dell'aniello S, Schiffrin A, Suissa S.

Pharmacoepidemiol Drug Saf. 2010 Apr;19(4):335-42. doi: 10.1002/pds.1834.

PMID:
20052677
5.

Associations between diabetes medication use and risk of second breast cancer events and mortality.

Calip GS, Yu O, Hoskins KF, Boudreau DM.

Cancer Causes Control. 2015 Aug;26(8):1065-77. doi: 10.1007/s10552-015-0599-z. Epub 2015 May 9.

6.

Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival.

Currie CJ, Poole CD, Jenkins-Jones S, Gale EA, Johnson JA, Morgan CL.

Diabetes Care. 2012 Feb;35(2):299-304. doi: 10.2337/dc11-1313. Epub 2012 Jan 20.

7.

Long-term effects of insulin glargine on the risk of breast cancer.

Suissa S, Azoulay L, Dell'Aniello S, Evans M, Vora J, Pollak M.

Diabetologia. 2011 Sep;54(9):2254-62. doi: 10.1007/s00125-011-2190-9. Epub 2011 May 26.

PMID:
21614572
8.

Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.

Baur DM, Klotsche J, Hamnvik OP, Sievers C, Pieper L, Wittchen HU, Stalla GK, Schmid RM, Kales SN, Mantzoros CS.

Metabolism. 2011 Oct;60(10):1363-71. doi: 10.1016/j.metabol.2010.09.012. Epub 2010 Nov 16.

PMID:
21081242
9.

Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer.

He X, Esteva FJ, Ensor J, Hortobagyi GN, Lee MH, Yeung SC.

Ann Oncol. 2012 Jul;23(7):1771-80. doi: 10.1093/annonc/mdr534. Epub 2011 Nov 22.

10.

Mortality in people with type 2 diabetes in the UK.

Mulnier HE, Seaman HE, Raleigh VS, Soedamah-Muthu SS, Colhoun HM, Lawrenson RA.

Diabet Med. 2006 May;23(5):516-21.

PMID:
16681560
11.

Clinical pathological characteristics and prognostic analysis of diabetic women with luminal subtype breast cancer.

Xiao Y, Zhang S, Hou G, Zhang X, Hao X, Zhang J.

Tumour Biol. 2014 Mar;35(3):2035-45. doi: 10.1007/s13277-013-1270-5. Epub 2013 Oct 5.

PMID:
24096546
12.

The association of diabetes with breast cancer incidence and mortality in the Long Island Breast Cancer Study Project.

Cleveland RJ, North KE, Stevens J, Teitelbaum SL, Neugut AI, Gammon MD.

Cancer Causes Control. 2012 Jul;23(7):1193-203. doi: 10.1007/s10552-012-9989-7. Epub 2012 May 22.

13.

Diabetes and breast cancer risk: a meta-analysis.

Boyle P, Boniol M, Koechlin A, Robertson C, Valentini F, Coppens K, Fairley LL, Boniol M, Zheng T, Zhang Y, Pasterk M, Smans M, Curado MP, Mullie P, Gandini S, Bota M, Bolli GB, Rosenstock J, Autier P.

Br J Cancer. 2012 Oct 23;107(9):1608-17. doi: 10.1038/bjc.2012.414. Epub 2012 Sep 20.

14.

Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults.

Calle EE, Murphy TK, Rodriguez C, Thun MJ, Heath CW Jr.

Cancer Causes Control. 1998 Aug;9(4):403-10.

PMID:
9794172
15.

Breast-feeding and cancer: the Boyd Orr cohort and a systematic review with meta-analysis.

Martin RM, Middleton N, Gunnell D, Owen CG, Smith GD.

J Natl Cancer Inst. 2005 Oct 5;97(19):1446-57. Review.

16.

Body mass index and mortality among older breast cancer survivors in the Study of Osteoporotic Fractures.

Reeves KW, Faulkner K, Modugno F, Hillier TA, Bauer DC, Ensrud KE, Cauley JA; Study of Osteoporotic Fractures Research Group.

Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1468-73.

17.

The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes.

Vissers PA, Cardwell CR, van de Poll-Franse LV, Young IS, Pouwer F, Murray LJ.

Breast Cancer Res Treat. 2015 Apr;150(2):427-37. doi: 10.1007/s10549-015-3331-5. Epub 2015 Mar 12.

PMID:
25762476
18.

Mortality and recurrence risk in relation to the use of lipid-lowering drugs in a prospective breast cancer patient cohort.

Nickels S, Vrieling A, Seibold P, Heinz J, Obi N, Flesch-Janys D, Chang-Claude J.

PLoS One. 2013 Sep 25;8(9):e75088. doi: 10.1371/journal.pone.0075088. eCollection 2013.

19.

Anthropometric predictors of breast cancer incidence and survival in a multi-ethnic cohort of female residents of Hawaii, United States.

Galanis DJ, Kolonel LN, Lee J, Le Marchand L.

Cancer Causes Control. 1998 Mar;9(2):217-24.

PMID:
9578299
20.

Antidiabetic drugs and heart failure risk in patients with type 2 diabetes in the U.K. primary care setting.

Maru S, Koch GG, Stender M, Clark D, Gibowski L, Petri H, White AD, Simpson RJ Jr.

Diabetes Care. 2005 Jan;28(1):20-6.

PMID:
15616228
Items per page

Supplemental Content

Write to the Help Desk